New Tests Launched in December

By Emily Linginfelter • January 10, 2019

Share this:

In December 2018, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests

New tests launched in December 2018 by Mayo Clinic Laboratories:

• • Calmodulin-Binding Transcription Activator 1 (CAMTA1), Immunostain, Technical Component Only (Mayo ID: CAMTA)
  • FosB, Immunostain, Technical Component Only (Mayo ID: BFOS)
  • Retinoblastoma Protein (Rb) Immunostain, Tech Only (Mayo ID: RB1)

Test Updates

In addition to these new tests, the department also announced several test changes. Click the links below to view test changes announced via Mayo Clinic Laboratories:

• All New Tests
• Test Changes
• Test Status Updates
• View All Updates

Emily Linginfelter

Emily Linginfelter is a Marketing Associate at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Emily has worked at Mayo Clinic since 2018.